Increasing evidence shows that SLC7A11/xCT, one of the vital regulators of intracellular antioxidants, has become a focal point for the synchronous regulation of these metabolic disorder‐associated PCDs [186]. This evidence concerns the gene SLC7A11 and Other metabolic disease.